상세 보기
Randomized, phase 3 study of second-line tislelizumab versus chemotherapy in advanced or metastatic esophageal squamous cell carcinoma, RATIONALE 302: Asia subgroup
- Zhao, Kuaile;
- Kim, Sung-Bae;
- Kato, Ken;
- Hsu, Chih-Hung;
- Hu, Sheng;
- ... Kim, Young Saing;
- 외 8명
Citations
WEB OF SCIENCE
1- 제목
- Randomized, phase 3 study of second-line tislelizumab versus chemotherapy in advanced or metastatic esophageal squamous cell carcinoma, RATIONALE 302: Asia subgroup
- 저자
- Zhao, Kuaile; Kim, Sung-Bae; Kato, Ken; Hsu, Chih-Hung; Hu, Sheng; Wang, Feng; Kojima, Takashi; Kim, Young Saing; Van Cutsem, Eric; Ajani, Jaffer A.; Li, Liyun; Ding, Ningning; Tao, Aiyang; Shen, Lin
- 발행일
- 2022-02-01
- 유형
- Meeting Abstract
- 권
- 40
- 호
- 4
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X